| 18 years and more
- | Country :
- France
- | organs :
- Prostate
- Métastases osseuses
- | Specialty :
- Thérapies Ciblées
Extract
A phase III trial to test the efficacy of ZD4054, an endothelin a receptor antagonist, versus placebo in patients with hormone resistant prostate cancer (HRPC) and bone metastasis who are pain free and mildly symptomatic.
Scientific Abstract
en cours d'intégration;